• sv
Contact
  • About us

    About us

    Orexo is a fully integrated specialty pharmaceutical company

     

    • CEO comments
    • Objectives & strategies
    • Business model
    • Key market
    • Financial information
    • Board of Directors & Management
    • Corporate Governance
    • Career
    • Meet us
    • History
  • Products

    Products

    Products approved worldwide

    • Zubsolv®
    • Abstral®
    • Edluar®
  • Pipeline

    Pipeline

    Our drug delivery technologies improve pharmaceuticals

    • Innovation
    • Technologies
    • Development projects
  • Partners

    Partners

    Partnerships are critical to our success

    • Gesynta Pharma AB
    • Kyowa Kirin International
    • Mundipharma
    • Mylan
    • Zydus Cadila
    • Partner contact
  • Sustainability

    Sustainability

    We will be recognized for the added value our products bring to patients and societies

    • Our team
    • People and society
    • Opioidcrisis
    • Our commitments
  • Investors

    Investors

    Orexo’s share is listed on Nasdaq Stockholm Mid Cap and available as American Depository Receipts (ADRs) on OTCQX in the US.

    • Financial calendar & events
    • Press releases
    • News
    • Reports, presentations and audiocasts
    • Analysts
    • Subscription
    • The share
    • Key market
    • Financial information & key figures
    • Prospectus
    • IR contact
  • Media

    Media

    Follow Orexo in social media

    • Press releases
    • News
    • Social media
    • Image bank
    • Press contact
  • Orexo
  • Investors
  • News
Top image

News

Show:
  • Latest 6 months
  • 2019
  • 2018
  • 2017
  • 2016
Loading...
  • Invitation to presentation of Orexo´s Full Year Report incl. Q4 2018, on January 30
    Jan 22 2019
  • Actavis infringes Orexo’s long term Zubsolv® US patent ´330
    Jan 11 2019
  • Orexo hosts Capital Markets Day today in Stockholm, Sweden
    Dec 6 2018
  • US Court of Appeals denies Actavis’s petition for rehearing regarding validity of the Zubsolv® patent
    Nov 30 2018
  • Agenda – Orexo Capital Markets Day, Stockholm, Sweden, Dec. 6
    Nov 28 2018
  • Orexo to host a Capital Markets Day on Dec. 6 with the US president´s former advisor as keynote speaker
    Nov 8 2018
  • Save the date: Orexo to host Capital Markets Day on Dec. 6 with the US president´s former advisor as key note speaker
    Oct 24 2018
  • Invitation: “The successful defence of Zubsolv® – Experiences from pharmaceutical patent litigation in the US”
    Oct 22 2018
  • 1
  • 2

Our drug delivery technologies improve pharmaceuticals

 

P.O. Box 303. SE-751 05 Uppsala, Sweden

Tel. +46 (0)18 780 88 00

info@orexo.com

 

©2019

Orexo AB (publ.) – All rights reserved

Contact | Dictionary & Definitions | Privacy Policy | Legal notice | Cookie policy Orexo US

This website intends to use cookies to improve the website and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information, Read more

Accept
Disclaimer
Return Continue